8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Whole Body / General1,971 citations

Kumar S, Behari J, Sisodia R

Bioeffects Seen

Authors not listed · 2012

Share:

Genetic variants affect diabetes risk differently in men and women, suggesting EMF health effects may also vary by genetics and sex.

Plain English Summary

Summary written for general audiences

Researchers analyzed genetic data from nearly 150,000 people to identify ten new genetic locations linked to type 2 diabetes risk. The study found that some genetic variants affect men and women differently, and identified biological processes like cell cycle regulation that contribute to diabetes development.

Why This Matters

While this study focuses on genetic factors in diabetes, it highlights an important gap in EMF research. We know that electromagnetic field exposure can disrupt endocrine function, including insulin regulation and glucose metabolism. Yet studies examining EMF effects on diabetes rarely consider genetic susceptibility factors like those identified here. The reality is that people with certain genetic variants may be more vulnerable to EMF-induced metabolic disruption. This research underscores why we need personalized approaches to EMF protection, especially for individuals with genetic predispositions to metabolic disorders.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2012). Kumar S, Behari J, Sisodia R.
Show BibTeX
@article{kumar_s_behari_j_sisodia_r_ce2469,
  author = {Unknown},
  title = {Kumar S, Behari J, Sisodia R},
  year = {2012},
  doi = {10.1038/ng.2383},
  
}

Quick Questions About This Study

The study identified ten previously unknown genetic locations that increase type 2 diabetes susceptibility. Two of these locations showed different effects in men versus women, suggesting sex-specific genetic pathways influence diabetes risk.
The meta-analysis included 149,821 participants - 34,840 people with type 2 diabetes and 114,981 healthy controls. Nearly all participants were of European descent, limiting applicability to other populations.
Yes, the study found that CREBBP-related transcription processes are involved in diabetes development. CREBBP is a protein that helps regulate gene expression, and disruptions in this pathway contribute to diabetes susceptibility.
Adipocytokine signaling involves hormones released by fat cells that affect metabolism and inflammation. The study identified disrupted adipocytokine pathways as one mechanism contributing to type 2 diabetes development.
The research implicated cell cycle regulation - the process controlling cell division and growth - in diabetes development. Disruptions in how cells reproduce and maintain themselves appear to contribute to diabetes susceptibility.